Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Ascentage Pharma Group International

Market Cap: HK$29.5b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Marinomed Biotech

Market Cap: €35.6m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Oscotec

Market Cap: ₩1.5t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

AprilBioLtd

Market Cap: ₩560.8b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Xbrane Biopharma

Market Cap: SEK 706.8m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

MedinCell

Market Cap: €565.6m

A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.

Bonesupport Holding

Market Cap: SEK 20.9b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

ALTEOGEN

Market Cap: ₩24.8t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Acrux

Market Cap: AU$5.3m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

RemeGen

Market Cap: HK$55.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Egetis Therapeutics

Market Cap: SEK 1.8b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥13.5b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Akeso

Market Cap: HK$137.9b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

EZZ Life Science Holdings

Market Cap: AU$98.6m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Guard Therapeutics International

Market Cap: SEK 463.9m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Mesoblast

Market Cap: AU$2.5b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Aether Industries

Market Cap: ₹100.2b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

OS Therapies

Market Cap: US$70.8m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.6b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Boji Medical TechnologyLtd

Market Cap: CN¥4.1b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$521.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Macrogen

Market Cap: ₩165.9b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

Ocumension Therapeutics

Market Cap: HK$7.5b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

PharmaResources (Shanghai)

Market Cap: CN¥5.2b

Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.

Eton Pharmaceuticals

Market Cap: US$461.0m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Grace Therapeutics

Market Cap: US$41.3m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Aelis Farma

Market Cap: €14.6m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Senores Pharmaceuticals

Market Cap: ₹32.8b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 135.3m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Genovis AB (publ.)

Market Cap: SEK 1.5b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Faron Pharmaceuticals Oy

Market Cap: UK£229.5m

Operates as a clinical stage drug discovery and development company.

Labiana Health

Market Cap: €31.0m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Kuros Biosciences

Market Cap: CHF 959.9m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Devyser Diagnostics

Market Cap: SEK 2.6b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.